sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Schedules Investor Webcast on Q4 2025 Financials
Jaguar Health, Inc. has announced a webcast for investors set for April 10, 2026, at 8:30 a.m. Eastern. The presentation will cover financials from the fourth quarter of 2025 and provide company updates. Interested participants can register through the company's website.
The webcast will include information on Jaguar's subsidiaries, Napo Pharmaceuticals and Napo Therapeutics, which develop treatments for rare gastrointestinal disorders. Additionally, Magdalena Biosciences, a joint venture with Filament Health Corp., focuses on plant-derived prescription medicines for mental health issues.
Jaguar highlights forward-looking statements in the press release, emphasizing that they rest on current expectations and are not guaranteed outcomes. These projections may be affected by unpredictable risks and uncertainties.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.